Meet the Experts sessions from UT MD Anderson are scheduled throughout ASH. Note: All times are listed in Eastern Time.
Saturday, December 6
11–11:30 a.m. ET
Insights on GVHD: From prevention to treatment
Professor, Stem Cell Transplantation and Cellular Therapy
Professor, Hematopoietic Biology and Malignancy
Professor, Stem Cell Transplantation and Cellular Therapy
11–11:30 a.m. ET
New directions in cell therapy
Vice President and Head, Institute for Cell Therapy Innovation and Discovery
Assistant Professor, Lymphoma and Myeloma
11:30 a.m.–12 p.m. ET
The new class of leukemia targets
Assistant Professor, Leukemia
Professor, Leukemia
3:15–3:45 p.m. ET
Decoding the latest CLL advances: Part I
Professor, Leukemia
4–4:30 p.m. ET
Clinical trials at UT MD Anderson
Division Head, Cancer Medicine
Professor and Chair Ad Interim, Leukemia
Sunday, December 7
11–11:30 a.m. ET
What's now, what's next: AI in hematopathology
Assistant Professor, Leukemia
Assistant Professor, Hematopathology
1–1:30 p.m. ET
Novel treatments for multiple myeloma
Assistant Professor, Lymphoma and Myeloma
Associate Professor, Lymphoma and Myeloma
2–2:30 p.m. ET
New treatment strategies for mantle cell lymphoma: Part I
Professor, Lymphoma and Myeloma
3:30–4 p.m. ET
Innovative approaches to aggressive lymphomas
Associate Professor, Lymphoma and Myeloma
4–4:30 p.m. ET
New treatment strategies for mantle cell lymphoma: Part II
Assistant Professor, Lymphoma and Myeloma
4–4:30 p.m. ET
Partnering with health systems to eliminate cancer
Professor, Stem Cell Transplantation and Cellular Therapy
Professor, Stem Cell Transplantation and Cellular Therapy
4:30–5 p.m. ET
Student opportunities at UT MD Anderson
Program Director, Med Students SOAR and RADAR
Monday, December 8
10–10:30 a.m. ET
CHIP/CCUS: What's ahead with therapeutic intervention
Assistant Professor, Leukemia
Assistant Professor, Leukemia
10–10:30 a.m. ET
Redefining gold standard of care in myeloid malignancies
Professor, Leukemia
Assistant Professor, Hematopoietic Biology and Malignancy
1:30–2 p.m. ET
Decoding the latest CLL advances: Part II
Professor, Leukemia
1:30–2 p.m. ET
New insights in indolent lymphomas
Assistant Professor, Lymphoma and Myeloma
Associate Professor, Lymphoma and Myeloma
Get to know our oncologists
Some of our experts who will be presenting at ASH 2025